Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04731740
Status:
WITHDRAWN
Last Update Posted:
2024-03-25
First Post:
2021-01-26
Brief Title:
Pembrolizumab and LenvatinibChemotherapy for Poorly DifferentiatedAnaplastic Thyroid Cancer
Sponsor:
Organization:
Saint Petersburg State University Russia